GENinCode Collaborates for Familial Hypercholesterolemia Screening

GENinCode Plc has announced a collaboration with The Family Heart Foundation, UT Southwestern, and other partners to use the LIPID inCode® test for diagnosing familial hypercholesterolemia (FH). This test will be deployed in US Primary and Secondary Care settings to prevent cardiovascular diseases.

Supported by a US Department of Defense grant, the DISCOVER FH1 mission aims to improve early diagnosis of FH through family screening. The LIPID inCode® tool helps identify patients and perform cascade screening, offering early treatment options and reducing heart disease risks.

The program will identify individuals from UT Southwestern Medical Center and the VA North Texas Health Care system. Post-diagnosis, the Family Heart Foundation will educate at-risk family members and coordinate further genetic testing.

Professor Zahid Ahmed emphasized the benefits of easy sample collection and reduced costs. Katie Wilemon, CEO of Family Heart Foundation, highlighted the importance of broader cascade screening to reduce preventable heart diseases.

Matthew Walls, CEO of GENinCode, stated the collaboration's goal to expand LIPID inCode testing for broader adoption and improved cardiovascular disease prevention.